A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）
Clinical trial NCT03137368 · UNKNOWN
Trial details
- NCT number
- NCT03137368
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2023-10-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.